Achiral and chiral HPLC analysis of norverapamil and its metabolites in microsomal samples

Citation
E. Brandsteterova et al., Achiral and chiral HPLC analysis of norverapamil and its metabolites in microsomal samples, NEOPLASMA, 46(4), 1999, pp. 207-211
Citations number
15
Categorie Soggetti
Onconogenesis & Cancer Research
Journal title
NEOPLASMA
ISSN journal
00282685 → ACNP
Volume
46
Issue
4
Year of publication
1999
Pages
207 - 211
Database
ISI
SICI code
0028-2685(1999)46:4<207:AACHAO>2.0.ZU;2-E
Abstract
Achiral and chiral HPLC (high performance liquid chromatography) were devel oped for monitoring norverapamil and its two metabolites in in vitro micros omal samples. Norverapamil is a chiral drug with the same ability as verapa mil in reversing MDR (multi-drug resistance) against some cytostatics. R(+) norverapamil is less cardiotoxic as S(-) enantiomer and so it could be app lied in higher concentrations. HPLC conditions were worked out for both achiral and chiral assays and very simple and effective preseparation procedure (SPE - solid phase extraction ) was used for microsomal sample as clean-up step before HPLC analysis. The total concentrations of norverapamil and its metabolites were calculate d from achiral chromatograms and the ratio of enantiomers were determined f rom chiral separations. The complete assay could be used for both in vitro and in vivo experiments.